✓
Summary
2
Billing Details
3
Payment
Select License Type
Please fill your details and select preferred payment gateway.
Select Payment Method
You will be redirected to Razorpay secure payment gateway to complete your purchase.
Order Summary
Advance Renal Cell Carcinoma Therapeutics Market
The advance renal cell carcinoma therapeutics market is poised for robust expansion, driven by the increasing prevalence of renal cell carcinoma (RCC) and the emergence of innovative targeted therapies and immuno-oncology agents. In 2026, the global market size is estimated at USD 5.2 billion, with projections indicating a rise to USD 10.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 10.9% during the forecast period.
Report ID
8087
Domain Name
Healthcare
Format
PPT, PDF, WORD, EXCEL
Single User License:
$4,950
Total (inclusive of all taxes):
$4,950
Secure Payment By
We accept all major credit cards
